NASDAQ : POCI
Precision Optics Corporation, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 4.65 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 51.02M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 51.02M |
| Enterprise Value | 45.24M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 10.97M |
| Shares Outstanding | 10.97M |
| Shares Change (YoY) | +25.63% |
| Shares Change (QoQ) | +40.41% |
| Owned by Insiders (%) | 19.49% |
| Owned by Institutions (%) | 36.32% |
| Float | 8.27M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.62 |
| Forward PS | 1.62 |
| PB Ratio | 2.51 |
| P/TBV Ratio | 4.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.28 |
| Quick Ratio | 1.79 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.69 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -22.26% |
| Return on Assets (ROA) | -8.41% |
| Return on Invested Capital (ROIC) | -24.82% |
| Return on Capital Employed (ROCE) | -14.93% |
| Weighted Average Cost of Capital (WACC) | 5.88% |
| Revenue Per Employee | $291,961 |
| Profits Per Employee | -$33,610 |
| Employee Count | 108 |
| Asset Turnover | 1.21 |
| Inventory Turnover | 7.06 |
Taxes
| Measure | Value |
|---|
| Income Tax | 4,958 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +9.16% |
| 50-Day Moving Average | 4.42 |
| 200-Day Moving Average | 4.62 |
| Relative Strength Index (RSI) | 60.50 |
| Average Volume (20 Days) | 20,792 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3,951 |
| Short Previous Month | 40,488 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | 0.06 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 31.53M |
| Gross Profit | 5.43M |
| Operating Income | -3.51M |
| Pretax Income | -3.62M |
| Net Income | -3.63M |
| EBITDA | -3.23M |
| EBIT | -3.51M |
| Loss Per Share | -$0.43 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 9.84M |
| Total Debt | 4.06M |
| Net Cash | 5.78M |
| Net Cash Per Share | $0.53 |
| Equity (Book Value) | 20.35M |
| Book Value Per Share | 1.85 |
| Working Capital | 11.28M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -1.55M |
| Capital Expenditures | -426,786 |
| Depreciation & Amortization | 279,277 |
| Net Borrowing | -623,701 |
| Free Cash Flow | -1.98M |
| FCF Per Share | -$0.18 |
Margins
| Measure | Value |
|---|
| Gross Margin | 17.22% |
| Operating Margin | -11.13% |
| Pretax Margin | -11.50% |
| Profit Margin | -11.51% |
| EBITDA Margin | -10.24% |
| EBIT Margin | -11.13% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -25.63% |
| Shareholder Yield | -25.63% |
| Earnings Yield | -9.15% |
| FCF Yield | -3.87% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 2, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.39 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |